Maravai Lifesciences Holdings (MRVI) Other Non Operating Income (2020 - 2026)
Maravai Lifesciences Holdings' (MRVI) quarterly Other Non Operating Income came in at -$494000.0 in Q1 2026, down 2158.33% year-on-year from $24000.0 in Q1 2025, and down 1048.84% quarter-over-quarter from -$43000.0 in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Other Non Operating Income (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Other Non Operating Income history runs 7 years deep, the most recent figure standing at -$494000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 2158.33% year-over-year to -$494000.0 in Q1 2026; TTM through Mar 2026 was -$4.7 million, a 42.86% decrease from a year earlier, with the FY2025 full-year figure at -$4.2 million, down 30.28% from the prior year.
- Other Non Operating Income eased to -$494000.0 in Q1 2026 per MRVI's latest filing, from -$43000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.4 million in Q4 2023 and bottomed at -$4.1 million in Q2 2025.
- The 5-year median for Other Non Operating Income is -$43000.0 (2025), against an average of -$464600.0.
- Biggest YoY gain for Other Non Operating Income was 429.35% in 2022; the steepest drop was 6766.67% in 2022.
- Year by year, Other Non Operating Income stood at $1.1 million in 2022, then surged by 30.26% to $1.4 million in 2023, then plunged by 157.94% to -$803000.0 in 2024, then jumped by 94.65% to -$43000.0 in 2025, then slumped by 1048.84% to -$494000.0 in 2026.
- Per Business Quant, the three latest MRVI Other Non Operating Income figures stand at -$494000.0 (Q1 2026), -$43000.0 (Q4 2025), and -$71000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Maravai Lifesciences Holdings | 1.03 Bn | 1.02 Bn | 33.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -494,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Sep 30, 2025 | -71,000.00 |
| Jun 30, 2025 | -4.06 Mn |
| Mar 31, 2025 | 24,000.00 |
| Dec 31, 2024 | -803,000.00 |
| Sep 30, 2024 | 72,000.00 |
| Jun 30, 2024 | -2.56 Mn |
| Mar 31, 2024 | 106,000.00 |
| Dec 31, 2023 | 1.39 Mn |
| Sep 30, 2023 | 66,000.00 |
| Jun 30, 2023 | -1.62 Mn |
| Mar 31, 2023 | 168,000.00 |
| Dec 31, 2022 | 1.06 Mn |
| Mar 31, 2022 | -200,000.00 |
| Dec 31, 2021 | 201,000.00 |
| Sep 30, 2021 | 78,000.00 |
| Jun 30, 2021 | -3,000.00 |
| Mar 31, 2021 | 3,000.00 |
| Dec 31, 2020 | -332,000.00 |